NanoVibronix, Inc.
For the period ended Nov 10, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Nov 10, 2025 · Filed Nov 10, 2025
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
NanoVibronix, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of Filing Fee (Check all boxes that apply): | |
|---|---|
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
November 10, 2025
Dear Stockholder:
You are cordially invited to attend the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of NanoVibronix, Inc., a Delaware corporation (“we,” “us,” “our” or the “Company”), which will be held on December 4, 2025, at 10:00 a.m. Eastern Time atwww.virtualshareholdermeeting.com/NAOV2025. To provide access to our stockholders regardless of geographic location, the Company has determined that the Annual Meeting will be a virtual meeting conducted exclusively via live webcast. You or your proxyholder will be able to attend the virtual Annual Meeting online, vote, and submit questions during the Annual Meeting by visitingwww.virtualshareholdermeeting.com/NAOV2025 and entering the 16-digit control number included on the proxy card or voting instruction form, as applicable. To receive access to the virtual Annual Meeting, registered stockholders and beneficial stockholders (those holding shares through a stock brokerage account or by a bank or other holder of record) will need to follow the instructions applicable to them provided in the accompanying proxy statement. Details regarding the Annual Meeting and the business to be conducted at the Annual Meeting are more fully described in the accompanying Notice of Annual Stockholders Meeting and proxy statement. You are entitled to vote at our Annual Meeting and any adjournments, continuations or postponements thereof only if you were a stockholder as of October 27, 2025.
Your vote is very important, regardless of the number of shares of our voting securities that you own. Whether or not you expect to attend the Annual Meeting online, please vote as promptly as possible to ensure your representation and the presence of a quorum at the Annual Meeting. To vote your shares, you may use the enclosed proxy card, vote by telephone or over the Internet, or attend the meeting virtually and submit your vote electronically. If your shares are held in the name of a broker, trust, bank or other nominee, and you receive these materials through your broker or through another intermediary, please complete and return the materials in accordance with the instructions provided to you by such broker or such other intermediary, or contact your broker directly in order to obtain a proxy issued to you by your nominee holder to virtually attend the meeting and vote online during the meeting. Failure to do so may result in your shares not being eligible to be voted by proxy at the meeting.
On behalf of the board of directors, I urge you to submit your vote as soon as possible, even if you currently plan to attend the Annual Meeting online.
Thank you for your support of our Company. I look forward to seeing you online at the Annual Meeting via remote communication.
Sincerely,
/s/ Doron Besser, M.D.
Doron Besser, M.D.
Chief Executive Officer and Director
NanoVibronix, Inc.
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held on December 4, 2025
The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of NanoVibronix, Inc., a Delaware corporation (“we,” “us,” “our” or the “Company”), will be held on December 4, 2025, at 10:00 a.m. Eastern Time, via a live webcast on the Internet. You will be able to virtually attend the Annual Meeting online, vote and submit questions during the Annual Meeting by visitingwww.virtualshareholdermeeting.com/NAOV2025. Only stockholders of record of our common stock, as of the close of business on October 27, 2025 (the “Record Date”), will be entitled to vote at the Annual Meeting and any adjournments, continuations or postponements thereof that may take place.
We will consider and act on the following items of business at the Annual Meeting:
| (1) | Election of the five nominees to serve on the Company’s board of directors (the “Board”) for a term of one year or until their respective successors are elected and qualified, for which the following are nominees: Doron Besser, M.D., Zeev Rotstein, M.D., David Johnson, Nino Pionati and Alison Geiger Burgett (the “Director Election Proposal”); |
| (2) | Ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (“E&Y”) as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (the “Auditor Ratification Proposal”); |
| (3) | Approval of an amendment to the NanoVibronix, Inc. 2024 Long-Term Incentive Plan to increase the total number of shares of common stock authorized for issuance under the 2024 Plan (the “Plan Amendment Proposal”); |
| (4) | To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock underlying shares of convertible preferred stock and warrants issued by us in a private placement in July 2025, in an amount equal to or in excess of 19.99% of our common stock outstanding before the issuance of such convertible preferred stock and warrants (including upon the operation of anti-dilution provisions applicable to such convertible preferred stock) (the “Issuance Proposal”); |
| (5) | Approval of a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals (the “Adjournment Proposal”); and |
| (6) | Such other business as may arise and that may properly be conducted at the Annual Meeting or any adjournment or postponement thereof. |
Stockholders are referred to the proxy statement accompanying this notice for more detailed information with respect to the matters to be considered at the Annual Meeting. After careful consideration, the “Board has determined that each proposal listed above is in the best interests of the Company and its stockholders and has approved each proposal.The Board recommends a vote “FOR” the election of each of the nominees for directors listed in the Director Ratification Proposal and “FOR” the Auditor Ratification Proposal, the Plan Amendment Proposal, the Issuance Proposal, and the Adjournment Proposal.
The Board has fixed the close of business on October 27, 2025, as the record date (the “Record Date”) for the Annual Meeting. Only stockholders of record of our common stock on the Record Date are entitled to receive notice of the Annual Meeting and vote at the Annual Meeting. A complete list of registered stockholders entitled to vote at the Annual Meeting will be available for inspection at the principal executive offices of the Company (upon request to us by mail at NanoVibronix, Inc., 969 Pruitt Place, Tyler TX 75703, Attn: Doron Besser, M.D., or by calling 914-233-3004 and asking for Doron Besser, M.D.) during regular business hours for the 10 calendar days prior to the Annual Meeting.
YOUR VOTE AND PARTICIPATION IN THE COMPANY’S AFFAIRS ARE IMPORTANT.
Whether or not you plan to attend the Annual Meeting online, we urge you to vote your shares as promptly as possible by Internet, telephone or mail. For specific instructions on how to vote your shares, please see the section entitled “About the Annual Meeting” beginning on page 2 of the proxy statement.
If your shares are registered in your name, even if you plan to attend the Annual Meeting (or any postponement or adjournment of the Annual Meeting) online, we request that you complete, date, sign and mail the proxy card in accordance with the instructions set out in the form of proxy and in the proxy statement to ensure that your shares will be represented at the Annual Meeting.
If your shares are held in the name of a broker, trust, bank or other nominee, and you receive these materials through your broker or through another intermediary, please complete and return the materials in accordance with the instructions provided to you by such broker or such other intermediary or contact your broker directly in order to obtain a proxy issued to you by your nominee holder to virtually attend the Annual Meeting and vote online. Failure to do so may result in your shares not being eligible to be voted by proxy at the Annual Meeting online.
By Order of the Board,
/s/ Doron Besser, M.D.
Doron Besser, M.D.
Chief Executive Officer and Director
November 10, 2025
TABLE OF CONTENTS
| ABOUT THE ANNUAL MEETING | 2 |
|---|---|
| PROPOSAL 1: ELECTION OF DIRECTORS | 9 |
| Directors and Company Nominees | 9 |
| CORPORATE GOVERNANCE | 12 |
| Code of Business and Ethics | 12 |
| Board Composition | 12 |
| Director Independence | 12 |
| Board Committees, Meetings, and Attendance | 13 |
| Board Leadership Structure | 14 |
| Role in Risk Oversight | 15 |
| Family Relationships and Involvement in Certain Legal Proceedings | 15 |
| Communications with Directors | 16 |
| Director Nominations | 17 |
| DIRECTOR COMPENSATION | 18 |
| CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS | 20 |
| EXECUTIVE COMPENSATION | 21 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 39 |
| REPORT OF THE AUDIT COMMITTEE | 41 |
| PROPOSAL 2: RATIFICATION OF APPOINTMENT OF Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 42 |
| PROPOSAL 3: APPROVAL OF NANOVIBRONIX, INC. 2024 LONG-TERM INCENTIVE PLAN | 44 |
| PROPOSAL 4: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS | 54 |
| PROPOSAL NO. 5: ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING TO APPROVE ONE OR MORE PROPOSALS PRESENTED AT THE ANNUAL MEETING | 59 |
| OTHER BUSINESS | 60 |
| SUBMISSION OF FUTURE STOCKHOLDER PROPOSALS | 60 |
i
NanoVibronix, Inc.
PROXY STATEMENT
FOR
ANNUAL MEETING OF STOCKHOLDERS
To Be Held on December 4, 2025
Unless the context otherwise requires, references in this proxy statement (this “Proxy Statement”) to “we,” “us,” “our,” “the Company,” or “NanoVibronix” refer to NanoVibronix, Inc., a Delaware corporation, and its consolidated subsidiary as a whole. In addition, unless the context otherwise requires, references to “stockholders” are to the holders of our common stock.
The accompanying proxy is solicited by the board of directors of the Company (the “Board”) on behalf of NanoVibronix, Inc. to be voted at the 2025 annual meeting of stockholders of the Company (the “Annual Meeting”) to be held virtually via a live webcast on the Internet on December 4, 2025, at 10:00 a.m. Eastern Time, at the Internet address and for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders (the “Notice”). This Proxy Statement and accompanying form of proxy are dated November 10, 2025, and are expected to be first sent, given or made available to stockholders on or about November 10, 2025.
If you held shares of our common stock at the close of business on October 27, 2025 (the “Record Date”), you are invited to attend the Annual Meeting virtually atwww.virtualshareholdermeeting.com/NAOV2025 and vote on the proposals described in this Proxy Statement.
We will pay the costs of soliciting proxies from stockholders. Our directors, officers and employees will solicit proxies on behalf of the Company, without additional compensation, by telephone, facsimile, mail, on the Internet or in person.
Our executive offices are located at, and our mailing address is 969 Pruitt Place, Tyler TX 75703.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 4, 2025:
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.